Chesapeake Partners Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Chesapeake Partners Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-30,000	Closed	-$2.73M	–	129
2015 Q1	$2.73M	Sell	30,000 -336,187	-92%	-$27.3M	0.13%	89
2014 Q4	$24.8M	Buy	366,187 +11,909	+3%	+$870K	0.95%	41
2014 Q3	$28.6M	Hold	354,278	–	–	1.06%	33
2014 Q2	$38M	Buy	354,278 +198,923	+128%	+$13.8M	1.15%	25
2014 Q1	$9.22M	Buy	+155,355	New	+$9.24M	0.36%	72

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Chesapeake Partners Management's GWPH Position: Q2 2015 in Review

Chesapeake Partners Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2015, closing a stake of 30,000 shares — an estimated $2.73M sold.

Chesapeake Partners Management first reported a position in GWPH in Q1 2014 and held it in 5 quarters. The position peaked at $38M in Q2 2014. 104 funds tracked by Wall St. Rank hold GWPH as of Q2 2015.

Chesapeake Partners Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2015 after selling out during the quarter.
Chesapeake Partners Management sold 30,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2015, an estimated $2.73M.
Chesapeake Partners Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 5 quarters.
Chesapeake Partners Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $38M in Q2 2014.
104 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2015.

Based on Chesapeake Partners Management's 13F filing for Q2 2015, filed 14 Aug 2015.